Medicare Overhaul Sets $457 Fixed Rate for Skin Substitutes and Mandates U.S. Manufacturing by 2027

The American Patients First Act of 2026 is a major shake-up for how Medicare handles advanced wound care. Starting January 1, 2027, the bill sets a flat payment of $457 per square centimeter for skin substitute products used to treat chronic or acute wounds. This moves away from the current system of fluctuating prices, aiming to stabilize costs for the government and patients alike. However, there is a catch for manufacturers: to get paid, these products must be 100% American-made. This means every bit of human tissue must be donated by U.S. citizens, and all processing and manufacturing must happen on U.S. soil (Sec. 2).

The 'Made in America' Mandate

This bill prioritizes domestic supply chains over global ones. For a patient, this could mean more reliable access to treatments if global shipping hits a snag, but it also creates a high bar for the industry. If a product uses materials from overseas, Medicare simply won't cover it unless the Secretary of Health and Human Services issues a temporary 180-day waiver because of a domestic shortage. For smaller medical tech companies or those with international partnerships, this is a massive pivot that could lead to higher production costs or even some products disappearing from the market entirely.

New Rules for Doctors and Clinics

If you are a healthcare provider, the bill adds several layers of red tape to ensure 'program integrity.' By 2027, Medicare will start reviewing claims before they are paid for 'high-volume' providers—specifically those where skin substitutes make up 15% or more of their claims. If a clinic has a habit of getting claims denied (a rate over 75%), they could be referred to the Inspector General for potential exclusion from federal programs (Sec. 3). Additionally, the bill stops Medicare from paying for more than three applications of a product if the wound isn't showing improvement, and it strictly limits payment for 'wastage' to prevent billing for oversized pieces of material.

Certification and Cost Floors

This isn't just about the products; it’s about who applies them. To get reimbursed, providers must hold specific certifications from recognized boards, like the American Board of Wound Management. This ensures a baseline of expertise, but it might squeeze out general practitioners who haven't sought these specific credentials. Interestingly, the bill also sets a 'price floor'—Medicare won't pay if a doctor bought the product for less than $342.75 per square centimeter. This is likely intended to prevent providers from pocketing massive profits by buying cheap and billing high, but it adds a unique layer of price regulation that the industry will have to navigate carefully.